# Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union

> **NCT03634319** · NA · TERMINATED · sponsor: **MicroOptx** · enrollment: 10 (actual)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

- **DEVICE:** Beacon Aqueous Microshunt

## Key facts

- **NCT ID:** NCT03634319
- **Lead sponsor:** MicroOptx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-01
- **Primary completion:** 2021-11-11
- **Final completion:** 2023-01-08
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Significant risks (e.g., infection, endothelial cell loss) and high rate of channel plugging associated with product use.
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634319, "Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03634319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*